^
    Back
    Association details:
    Biomarker:No biomarker
    Cancer:Rectal Cancer
    Drug:Enhertu (fam-trastuzumab deruxtecan-nxki) (Topoisomerase I inhibitor, HER2-targeted antibody-drug conjugate)
    Direction:Sensitive
    Evidence:
    Evidence Level:
    Sensitive: A2 - Guideline
    New
    Source:
    NCCN
    Excerpt:
    Rectal cancer: Systemic therapy for advanced or metastatic disease…Fam-trastuzumab deruxtecan-nxki